GlassScriptPhysician profile
Melissa R Lamaster
NPI 1780094185
$1,807.10
in general payments reported to CMS, 2019-2025
25 companies · $529 in 2025
The $529 reported for 2025 was more than what a typical Nurse Practitioner provider received nationally (typical 2025 total: $174).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $330 · 2022: $268 · 2023: $238 · 2024: $443 · 2025: $529.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,209.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,209.33 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $319.98 | 2021-2025 | |
| Novo Nordisk INC | $260.58 | 2021-2025 | Ozempic, Rybelsus, Wegovy |
| Medtronic, INC. | $231.05 | 2025 | Symplicity G3 |
| Astrazeneca Pharmaceuticals LP | $163.75 | 2021-2024 | Farxiga, Airsupra |
| Lilly USA, LLC | $144.80 | 2021-2025 | Mounjaro, Jardiance, Zepbound |
| Boehringer Ingelheim Pharmaceuticals, INC. | $98.90 | 2021-2025 | Jardiance |
| Amgen INC. | $98.71 | 2021-2025 | Repatha, Repatha, Otezla |
| Glaxosmithkline, LLC. | $88.44 | 2021-2025 | Trelegy Ellipta, Arexvy |
| Exact Sciences Corporation | $79.22 | 2023-2025 | Cologuard Collection Kit |
| Pfizer INC. | $52.65 | 2024-2025 | |
| Dynavax Technologies Corporation | $33.57 | 2024-2025 | Heplisav-B |
| Merck Sharp & Dohme LLC | $27.50 | 2021 | |
| Mylan Specialty L.P. | $19.54 | 2021 | |
| Abiomed | $18.94 | 2024 | Impella |
| Celgene Corporation | $18.02 | 2025 | Zeposia |
Show all 25 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bausch Health US, LLC | $17.87 | 2023 | Aplenzin, Wellbutrin |
| Biohaven Pharmaceutical Holding Company LTD. | $17.59 | 2022 | |
| Astellas Pharma US INC | $16.07 | 2024 | Veozah |
| Hologic Sales and Service, LLC | $15.53 | 2022 | |
| Otsuka America Pharmaceutical, INC. | $15.37 | 2024 | Rexulti |
| Bayer Healthcare Pharmaceuticals INC. | $15.26 | 2024 | |
| Vanda Pharmaceuticals INC. | $15.19 | 2025 | Fanapt, Hetlioz |
| Sanofi Pasteur INC. | $13.33 | 2022 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $13.19 | 2022 | |
| Kowa Pharmaceuticals America, INC. | $12.05 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Melissa Lamaster listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.